Provepharm

One lot of Phenylephrine hydrochloride Injection, USP, 10 mg/mL is being recalled due to particulate matter found in a vial.

Provepharm enters fluorescence imaging market with US and UK launch of Zyogreen, its ready-to-use indocyanine green dye. First move into fluorescence imaging market follows recent FDA and MHRA approvals of Zyogreen and commercial launches in the US and th

Sagent Pharmaceuticals ("Sagent"), a leading provider of injectables to the U.S. market, is excited to announce a strategic partnership with Provepharm to commercialize three innovative diagnostic dyes, beginning with Bludigo (indigotindisulfonate sodium)

The deal includes four FDA-approved and marketed sterile injectable drugs and two late-stage pipeline assets.

Provepharm obtains B Corp certification. Company joins exclusive club of pioneering B Corp-certified pharmaceutical companies Marseille, France, November 29, 2023 - Provepharm, a leading international pharmaceutical company speci

Provence Technologies, a specialist fine chemistry research group, and its subsidiary Provepharm, developers of pharmaceutical applications, have invested in a new head office in Marseille. The investment will also fund the launch of a specialist incubato

Document de référence Déclarer un effet indésirable de vos démarche